{"doi":"10.4161/onci.25773","title":"Improving macrophage responses to therapeutic antibodies by molecular engineering of SIRPα variants","abstract":null,"journal":"OncoImmunology","year":2013,"id":628086,"datarank":0.3958585994422889,"base_score":2.639057329615259,"endowment":2.639057329615259,"self_citation_contribution":0.3958585994422889,"citation_network_contribution":0.0,"self_endowment_contribution":0.3958585994422889,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":13,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1626040,"name":"Aaron M Ring","orcid":null,"position":1,"is_corresponding":false},{"id":1626041,"name":"Peter J Schnorr","orcid":null,"position":2,"is_corresponding":false},{"id":1624478,"name":"Jens-Peter Volkmer","orcid":null,"position":3,"is_corresponding":false},{"id":1626042,"name":"Anne Kathrin Volkmer","orcid":null,"position":4,"is_corresponding":false},{"id":1455020,"name":"Irving L Weissman","orcid":null,"position":5,"is_corresponding":false},{"id":1626043,"name":"K Christopher Garcia","orcid":null,"position":6,"is_corresponding":false},{"id":990874,"name":"Kipp Weiskopf","orcid":"0000-0002-9008-445X","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Improving macrophage responses to therapeutic antibodies by molecular engineering of SIRPα variants","abstract":"CD47 transduces inhibitory signals through signal-regulatory protein α (SIRPα), a plasma membrane receptor expressed by macrophages. Many cancers upregulate CD47 to evade immunosurveillance. We have recently engineered SIRPα variants that potently antagonize CD47 for use as anticancer immunotherapeutics. These high-affinity SIRPα variants synergize with antineoplastic antibodies by lowering the threshold for macrophage-mediated destruction of malignant cells.","is_dataset_classified":null,"base_score":2.639057329615259,"endowment":2.639057329615259,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"24319639","pmcid":"PMC3850276","openalex_id":"https://openalex.org/W1999189249","authors":[],"funders":[{"funder_name":"NCI NIH HHS","grant_id":"R01 CA177684","title":null},{"funder_name":"NIDDK NIH HHS","grant_id":"F30 DK094541","title":null},{"funder_name":"NCI NIH HHS","grant_id":"P01 CA139490","title":null},{"funder_name":"NCI NIH HHS","grant_id":"F30 CA168059","title":null},{"funder_name":"NCI NIH HHS","grant_id":"R01 CA112270","title":null}],"total_grants":5,"fwci":1.2134,"citation_percentile":0.77270299,"influential_citations":0,"citation_trend":[{"year":2014,"count":4},{"year":2015,"count":2},{"year":2016,"count":3},{"year":2017,"count":2},{"year":2019,"count":1},{"year":2021,"count":1}],"oa_status":"gold","license":"cc-by-nc","oa_locations":[{"url":"https://www.tandfonline.com/doi/pdf/10.4161/onci.25773?needAccess=true","host_type":"journal"},{"url":"https://www.tandfonline.com/doi/pdf/10.4161/onci.25773?needAccess=true","host_type":"publisher"},{"url":"http://www.tandfonline.com/doi/pdf/10.4161/onci.25773","host_type":"publisher"},{"url":"https://doi.org/10.4161/onci.25773","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/24319639","host_type":"repository"},{"url":"http://europepmc.org/articles/PMC3850276","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3850276","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC3850276","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC3850276?pdf=render","host_type":"Europe_PMC"}],"fields_of_study":["Phagocytosis and Immune Regulation","Erythrocyte Function and Pathophysiology","Pancreatic function and diabetes"],"mesh_terms":[],"keywords":["CD47","Immunosurveillance","Macrophage","Antibody","Cancer research","Downregulation and upregulation","Immunotherapy","Biology","Immunology","Immune system","Cell biology","Chemistry","In vitro","Gene","Genetics","Cancer","Phagocytosis","Molecular engineering","Immune Checkpoint","Sirpa"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-05T11:03:51.710672Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}